Eiichi Fuse

2.3k total citations
36 papers, 1.9k citations indexed

About

Eiichi Fuse is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Eiichi Fuse has authored 36 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 17 papers in Pharmacology and 9 papers in Molecular Biology. Recurrent topics in Eiichi Fuse's work include Pharmacogenetics and Drug Metabolism (17 papers), Drug Transport and Resistance Mechanisms (16 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Eiichi Fuse is often cited by papers focused on Pharmacogenetics and Drug Metabolism (17 papers), Drug Transport and Resistance Mechanisms (16 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Eiichi Fuse collaborates with scholars based in Japan, United States and Singapore. Eiichi Fuse's co-authors include Yuichi Sugiyama, Hiroyuki Kusuhara, William D. Figg, Takashi Kuwabara, Harunobu Tahara, Junko Ushiki, Hiroshi Kodaira, Edward A. Sausville, Yukio Ando and Susan G. Arbuck and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Journal of Medicinal Chemistry.

In The Last Decade

Eiichi Fuse

36 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eiichi Fuse Japan	20	1.1k	762	409	322	141	36	1.9k
Edna F. Choo United States	24	797 0.7×	1.0k 1.3×	281 0.7×	286 0.9×	71 0.5×	54	1.9k
Lu-Bin Lan United States	16	1.1k 1.0×	746 1.0×	379 0.9×	549 1.7×	103 0.7×	19	2.0k
Norman E. Sládek United States	32	876 0.8×	1.9k 2.5×	249 0.6×	935 2.9×	106 0.8×	80	3.7k
Miyuki Shimane Japan	16	1.5k 1.3×	1.6k 2.1×	636 1.6×	163 0.5×	143 1.0×	17	3.2k
Jun-ichi Sawada Japan	20	751 0.7×	696 0.9×	258 0.6×	243 0.8×	69 0.5×	42	1.4k
Isabelle Dussault United States	23	1.4k 1.2×	1.0k 1.4×	193 0.5×	684 2.1×	86 0.6×	65	2.8k
Ryo Atsumi Japan	18	1.2k 1.1×	705 0.9×	116 0.3×	255 0.8×	176 1.2×	39	2.1k
Simon Joel United Kingdom	19	359 0.3×	652 0.9×	250 0.6×	111 0.3×	181 1.3×	36	1.7k
Charity D. Scripture United States	14	757 0.7×	541 0.7×	98 0.2×	219 0.7×	72 0.5×	25	1.8k
Serena Marchetti Netherlands	19	836 0.7×	577 0.8×	151 0.4×	155 0.5×	57 0.4×	48	1.4k

Countries citing papers authored by Eiichi Fuse

Since Specialization

Citations

This map shows the geographic impact of Eiichi Fuse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiichi Fuse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiichi Fuse more than expected).

Fields of papers citing papers by Eiichi Fuse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiichi Fuse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiichi Fuse. The network helps show where Eiichi Fuse may publish in the future.

Co-authorship network of co-authors of Eiichi Fuse

This figure shows the co-authorship network connecting the top 25 collaborators of Eiichi Fuse. A scholar is included among the top collaborators of Eiichi Fuse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiichi Fuse. Eiichi Fuse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kodaira, Hiroshi, Hiroyuki Kusuhara, Eiichi Fuse, Junko Ushiki, & Yuichi Sugiyama. (2014). Quantitative Investigation of the Brain-to-Cerebrospinal Fluid Unbound Drug Concentration Ratio under Steady-State Conditions in Rats Using a Pharmacokinetic Model and Scaling Factors for Active Efflux Transporters. Drug Metabolism and Disposition. 42(6). 983–989. 18 indexed citations

Kodaira, Hiroshi, Hiroyuki Kusuhara, Takuya Fujita, et al.. (2011). Quantitative Evaluation of the Impact of Active Efflux by P-Glycoprotein and Breast Cancer Resistance Protein at the Blood-Brain Barrier on the Predictability of the Unbound Concentrations of Drugs in the Brain Using Cerebrospinal Fluid Concentration as a Surrogate. Journal of Pharmacology and Experimental Therapeutics. 339(3). 935–944. 106 indexed citations

Kodaira, Hiroshi, Hiroyuki Kusuhara, Junko Ushiki, Eiichi Fuse, & Yuichi Sugiyama. (2010). Kinetic Analysis of the Cooperation of P-Glycoprotein (P-gp/Abcb1) and Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting the Brain and Testis Penetration of Erlotinib, Flavopiridol, and Mitoxantrone. Journal of Pharmacology and Experimental Therapeutics. 333(3). 788–796. 218 indexed citations

Ishida, Hiroshi, Yoshinori Yamashita, Jiro Kajita, et al.. (2008). Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as selective FLT3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5472–5477. 9 indexed citations

Ohta, Kiminori, Eri Arai, Yuji Nomoto, et al.. (2008). Synthetic study of VLA-4/VCAM-1 inhibitors: Synthesis and structure–activity relationship of piperazinylphenylalanine derivatives. Bioorganic & Medicinal Chemistry Letters. 18(3). 1053–1057. 12 indexed citations

Nagata, Yoshinori, et al.. (2008). P-glycoprotein Limits the Brain Penetration of Olopatadine Hydrochloride, H1-Receptor Antagonist. Drug Metabolism and Pharmacokinetics. 23(2). 106–114. 15 indexed citations

Sugiyama, Yuka, et al.. (2007). Effect of Benidipine on Simvastatin Metabolism in Human Liver Microsomes. Drug Metabolism and Pharmacokinetics. 22(3). 199–205. 4 indexed citations

Tahara, Harunobu, Hiroyuki Kusuhara, Kazuya Maeda, et al.. (2006). INHIBITION OF OAT3-MEDIATED RENAL UPTAKE AS A MECHANISM FOR DRUG-DRUG INTERACTION BETWEEN FEXOFENADINE AND PROBENECID. Drug Metabolism and Disposition. 34(5). 743–747. 58 indexed citations

Tahara, Harunobu, Hiroyuki Kusuhara, Michihiro Chida, Eiichi Fuse, & Yuichi Sugiyama. (2006). Is the Monkey an Appropriate Animal Model to Examine Drug-Drug Interactions Involving Renal Clearance? Effect of Probenecid on the Renal Elimination of H2 Receptor Antagonists. Journal of Pharmacology and Experimental Therapeutics. 316(3). 1187–1194. 43 indexed citations

10.

Tahara, Harunobu, Hiroyuki Kusuhara, Hitoshi Endou, et al.. (2005). A Species Difference in the Transport Activities of H2 Receptor Antagonists by Rat and Human Renal Organic Anion and Cation Transporters. Journal of Pharmacology and Experimental Therapeutics. 315(1). 337–345. 137 indexed citations

11.

Tahara, Harunobu, Hiroyuki Kusuhara, Eiichi Fuse, & Yuichi Sugiyama. (2005). P-GLYCOPROTEIN PLAYS A MAJOR ROLE IN THE EFFLUX OF FEXOFENADINE IN THE SMALL INTESTINE AND BLOOD-BRAIN BARRIER, BUT ONLY A LIMITED ROLE IN ITS BILIARY EXCRETION. Drug Metabolism and Disposition. 33(7). 963–968. 98 indexed citations

12.

Zhai, Suoping, Edward A. Sausville, Adrian M. Senderowicz, et al.. (2003). Clinical pharmacology and pharmacogenetics of flavopiridol 1-h i.v. infusion in patients with refractory neoplasms. Anti-Cancer Drugs. 14(2). 125–135. 20 indexed citations

13.

Kajita, Jiro, Eiichi Fuse, Takashi Kuwabara, & Hiroyuki Kobayashi. (2003). The Contribution of Cytochrome P450 to the Metabolism of Tegafur in Human Liver. Drug Metabolism and Pharmacokinetics. 18(5). 303–309. 25 indexed citations

14.

Kuwabara, Takashi, et al.. (2001). Pharmacokinetics, distribution, metabolism and excretion of [ 3 H]UCN-01 in rats and dogs after intravenous administration. Cancer Chemotherapy and Pharmacology. 47(2). 106–112. 4 indexed citations

15.

Fuse, Eiichi, Natsuko Sato, Hiromi Tanii, et al.. (2000). Physiological modeling of altered pharmacokinetics of a novel anticancer drug, UCN-01 (7-hydroxystaurosporine), caused by slow dissociation of UCN-01 from human alpha1-acid glycoprotein.. Pharmaceutical Research. 17(5). 553–564. 25 indexed citations

16.

Kuwabara, Takashi, Hiromi Tanii, Eiichi Fuse, et al.. (1999). Pharmacokinetics and pharmacodynamics of a novel protein kinase inhibitor, UCN-01. Cancer Chemotherapy and Pharmacology. 44(1). 12–18. 19 indexed citations

17.

Sausville, Edward A., Donna Headlee, Adaline C. Smith, et al.. (1998). Clinical pharmacology of UCN-01: Initial observations and comparison to preclinical models. Cancer Chemotherapy and Pharmacology. 42(S1). S54–S59. 71 indexed citations

18.

Yamaguchi, Kazuo, et al.. (1998). Development of a sensitive liquid chromatography–electrospray ionization tandem mass spectrometry method for the measurement of 7-cyanoquinocarcinol in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 713(2). 447–451. 3 indexed citations

19.

Fuse, Eiichi, et al.. (1996). Hepatic extraction ratio of 5-fluorouracil in rats. Biochemical Pharmacology. 52(4). 561–568. 8 indexed citations

20.

Fuse, Eiichi, Shunsuke Kobayashi, Masafumi Inaba, Hiroto Suzuki, & Yasuyuki Sugiyama. (1994). Application of Pharmacokinetically Guided Dose Escalation With Respect to Cell Cycle Phase Specificity. JNCI Journal of the National Cancer Institute. 86(13). 989–996. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact